openPR Logo
Press release

Ulcerative Colitis Market Treatment Analysis with Major Players Like AbbVie Inc., Merck Co., Johnson and Johnson During 2019-2024

04-23-2019 07:01 PM CET | Health & Medicine

Press release from: Market Prognosis

The ulcerative colitis market was valued at USD 6,854.47 million in 2018, and is also expected to register a CAGR of 4.86% during the forecast period (2019-2024). Ulcerative colitis (UC) is the most common form of inflammatory bowel disease which affects several people. From a global perspective, several research studies in 2018 have reported annual incidence rates of UC ranging from 0.5 to 24.5 cases per 100,000 people. On the other hand, incidences have been increasing in Asian and South European countries. In the United States, UC affects an estimated 500,000 people and is the cause of 250,000 doctor visits and 30,000 hospitalizations, each year. UC has an uneven presence in major geographical regions across the world. It is common in most of Europe and North America and uncommon in most of the developing Asian countries. UC is more prevalent among males and has a regional north-to-south variation. One potential explanation is the differences in exposure to ultraviolet light, resulting in relative vitamin D deficiency in countries close to the Arctic. People who live in lower latitudes are more likely to develop UC than those in higher latitudes.

Detailed Sample Copy of Updated Analysis @ https://marketprognosis.com/sample-request/19877
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

According to the Centers for Disease Control and Prevention (CDC), in 2015, 1.3% of US adults (3 million) reported that they were diagnosed with IBD (either Crohn’s disease or UC). This was a large increase in number from 1999 (0.9% or 2 million adults). According to an article published in PubMed, the highest reported prevalence values were in Europe (UC - 505 per 100,000 people in Norway, Crohn's disease - 322 per 100,000 people in Germany) and North America (UC - 286 per 100,000 people in the United States, Crohn's disease - 319 per 100,000 people in Canada). The high prevalence of the disease is driving the market.

Competitive Landscape
The ulcerative colitis market consists of several major players, including AbbVie Inc., Merck Co., Johnson and Johnson, and many others. The companies are implement certain strategic initiatives, such as merger, new product launch, acquisition, and partnerships that help them in strengthening their market position. For instance, in May 2018, Takeda Pharmaceutical Company Limited and Shire PLC announced that they reached an agreement on the terms of a recommended offer pursuant to which Takeda will acquire the entire issued and to be issued ordinary share capital of Shire.

Request Discount on this report @ https://marketprognosis.com/discount-request/19877
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Scope of the Report
As per the scope of the report, ulcerative colitis is a chronic, inflammatory bowel disease that causes inflammation in the digestive tract. Treatment for ulcerative colitis includes medication and surgery. However, the scope of this report includes only medications for the ulcerative colitis disease.

Key Market Trends
Ulcerative Proctitis Segment is Expected to Experience the Fastest Growth during the Forecast Period
Ulcerative proctitis is one of the types of ulcerative colitis. It is considered as the initial manifestation of ulcerative colitis, in which fine ulcerations in the inner linings of mucosa of the large intestine are seen. A survey was conducted by NIH in 2016, to understand the prevalence of disease, which gave results, such as 25% of the pediatric patients surveyed had the disease, and 17 to 21% of the adult patients had ulcerative proctitis. As per this data obtained by the survey, NIH stated that there was a rise in the number of patients suffering from ulcerative proctitis, compared to the previous years. Hence, this segment, by disease type, is believed to experience growth in the future.

North America Region Holds the Largest Market Share of the Ulcerative Colitis Market Currently and is Believed to Follow the Same Trend over the Forecast Period
North America is expected to lead the ulcerative colitis market, owing to the presence of key players and increasing prevalence of the disease in the region, along with the continuing funding for the development of new therapeutics for the treatment of the condition.

Enquiry Before Buying @ https://marketprognosis.com/enquiry/19877
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMark Pvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ulcerative Colitis Market Treatment Analysis with Major Players Like AbbVie Inc., Merck Co., Johnson and Johnson During 2019-2024 here

News-ID: 1714688 • Views: 569

More Releases from Market Prognosis

Technological Advancement in Global Mobile Advertising Market Forecast to 2026 …
Global Mobile Advertising Market Report 2019 offers elaborated knowledge on the market parts like size, Key Regions, growth, trends, dominating firms, Major Manufactures. The Mobile Advertising report introduces market competition situation among the vendors, revenue, product & services, latest developments and business strategies. Overview of the Global Mobile Advertising Market: The Global Mobile Advertising Market is accounted for $30.98 Billion in 2017 and is expected to reach $214.75 Billion by 2026 growing
Mining Chemicals Market Analysis and Forecast Report 2019 - 2026 with Estimated …
Global Mining Chemicals Market research report 2019 - 2026 provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. Overview of the Global Mining Chemicals Market: The Global Mining Chemicals Market is accounted for $6.11 Billion in 2017 and is expected to reach $10.01 Billion by 2026 growing at a CAGR of 5.6%. Significant factors which are influencing the market
Implantable Biomaterials Market Covering Prime Factors and Competitive Outlook T …
This comprehensive Implantable Biomaterials Market research report 2019 – 2026 includes a brief on these trends that can help the businesses operating in the industry to understand the market and strategize for their business expansion accordingly. The research report analyzes the market size, industry share, growth, key segments, CAGR and key drivers. Overview of the Global Implantable Biomaterials Market: The Global Implantable Biomaterials Market is accounted for $96.11 Billion in 2017 and
Booming Growth in Global Semi-Trailer Market and Forecast to 2023 by Worldwide T …
The report covers a forecast and an analysis of the Semi-Trailer Market on a global and regional level. The study provides historical data for 2016, 2017, and 2018 along with a forecast from 2019 to 2023 based on revenue and volume. Overview of the Global Semi-Trailer Market: The report spread across 89 pages is an overview of the Global Semi-Trailer Market - Analysis of Growth, Trends and Forecasts (2018 - 2023). These

All 5 Releases


More Releases for Ulcerative

Global Drug for Ulcerative Colitis Market Insights, Forecast to 2025
Market Research Report Store offers a latest published report on Drug for Ulcerative Colitis Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 158 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/323102/global-drug-for-ulcerative-colitis-market   Anti-inflammatory drugs are often the
Drug for Ulcerative Colitis Market Insights, Forecast by 2025
This recently published report examines the global Drug for Ulcerative Colitis market for the projected period of 7-years, i.e. between 2018 and 2025. The report highlights the accomplishments and opportunities lies in the market throughout the forecasted period. The report offers the thorough information about the overview and the scope of the global Drug for Ulcerative Colitis market along with its drivers, restraints, and trends. It also classifies the market
Ulcerative Colitis Market Absolute Analysis & Worldwide Foresight to 2022
Market research future has a half cooked research report on Global Ulcerative Colitis Market. Global Ulcerative Colitis Market is growing rapidly and expected to continue its growth by the end of 2022. The global Ulcerative colitis market has been evaluated as growing market and expected that the market will reach high growth figures in the coming future. Ulcerative colitis is a type of inflammatory bowel disease (IBD) that usually affects the
Ulcerative Colitis Market 2022: Global Analysis By Trend & Key Players
Ulcerative Colitis Market Analysis, by Medication (5-Aminosalicylates, Steroids, Purine Analogs, Immunomodulators, and Biologics) by type (Ulcerative Proctitis, Proctosigmoiditis, Left-Sided Colitis, Pancolitis or Universal Colitis, and Fulminant Colitis), - Forecast to 2022 Market Synopsis of Global Ulcerative Colitis Market: Market Scenario: Ulcerative colitis is a type of inflammatory bowel disease (IBD) that affects the colon and rectum part of human body. Inflammation and ulcers are formed in the innermost lining of the colon and
Ulcerative Colitis Market and Forecast Analysis
Boston, MA ReportsWorldwide has announced the addition of a new report title Ulcerative Colitis Market and Forecast Analysis to its growing collection of premium market research reports. Ulcerative colitis is a chronic inflammatory bowel disease that is characterized by inappropriate diffuse inflammation of the rectal and colonic mucosa, which occurs in the innermost layer of the intestinal lining. Ulcerative colitis is a chronic, incurable disease with low mortality that is generally diagnosed
Ulcerative Colitis Market
Ulcerative colitis is the most common type of inflammatory bowel disease that affects the colon (lining of the large intestine) and rectum. The inflammation produces tiny sores called ulcers. These disease can affect people of any age, though prevalence is especially high among people under 30 years of age. The major symptoms of this disease are diarrhea, belly pain/cramps, bleeding from the rectum, also other indications are sudden and unexplained